Mr Hiren Patel

Qualifications

PhD, FRCS (SN)

GMC number: 4182775

Practising since: 2006

Specialties

Neurosurgery

  • Overview
Enquire now

Or call us on

0161 521 9200

About

Mr Hiren Patel is a Consultant Neurosurgeon at the Manchester Institute of Health and Performance. Holding a PhD and having completed a prestigious clinical lecturer post at Cambridge University, Mr Patel bridges the gap between academic research and frontline clinical care. He currently serves as a neurovascular surgeon at Salford Royal Hospital and maintains a significant academic presence as an honorary senior lecturer at the University of Manchester.

Mr Patel’s research has had a profound impact on British medicine. His observations published in The Lancet fundamentally changed the national standards for head injury management, and he led the transformation of how neuro-trauma care is delivered across Greater Manchester. He is currently one of the few specialists in the United Kingdom with the unique skill set to treat brain aneurysms using both traditional open surgical approaches and advanced endovascular techniques, ensuring his patients receive the most appropriate, tailored intervention available.

In addition to his clinical duties, Mr Patel is a key figure in national healthcare quality improvement. He established and currently manages the National SAH outcome database and serves as a vital member of the national team dedicated to improving recovery outcomes after brain haemorrhages.

When away from the operating theatre or the lecture hall, Hiren enjoys the outdoors with his wife and two energetic sons. He is an avid skier and spends his leisure time attempting to master the intricacies of tennis and golf.

Special interests

  • Neurosurgery
  • Head Injuries
  • Concussion

Languages spoken

English

Locations Mr Hiren Patel works with

Related experience

Research

  1. Are do-not-resuscitate orders associated with limitations of care beyond their intended purpose in patients with acute intracerebral haemorrhage? Analysis of the ABC-ICH study
  2. Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort study
  3. Anakinra in COVID-19: important considerations for clinical trials
  4. An intracerebral haemorrhage care bundle is associated with lower case-fatality
  5. The self-reported needs of patients following subarachnoid haemorrhage (SAH) Self-Reported Needs after SAH
  6. CT angiogram negative perimesencephalic subarachnoid haemorrhage: is a subsequent DSA necessary? A systematic review

Memberships

  • Society of British Neurological Surgeons